151 related articles for article (PubMed ID: 36635046)
1. Secondary findings in a large Pakistani cohort tested with whole genome sequencing.
Skrahin A; Cheema HA; Hussain M; Rana NN; Rehman KU; Kumar R; Oprea G; Ameziane N; Rolfs A; Skrahina V
Life Sci Alliance; 2023 Mar; 6(3):. PubMed ID: 36635046
[TBL] [Abstract][Full Text] [Related]
2. Secondary genomic findings in the 2020 China Neonatal Genomes Project participants.
Xiao H; Zhang JT; Dong XR; Lu YL; Wu BB; Wang HJ; Zhao ZY; Yang L; Zhou WH
World J Pediatr; 2022 Oct; 18(10):687-694. PubMed ID: 35727495
[TBL] [Abstract][Full Text] [Related]
3. Landscape of Secondary Findings in Chinese Population: A Practice of ACMG SF v3.0 List.
Huang Y; Liu B; Shi J; Zhao S; Xu K; Sun L; Chen N; Tian W; Zhang J; Wu N
J Pers Med; 2022 Sep; 12(9):. PubMed ID: 36143288
[TBL] [Abstract][Full Text] [Related]
4. Actionable secondary findings following exome sequencing of 836 non-obstructive azoospermia cases and their value in patient management.
Kasak L; Lillepea K; Nagirnaja L; Aston KI; Schlegel PN; Gonçalves J; Carvalho F; Moreno-Mendoza D; Almstrup K; Eisenberg ML; Jarvi KA; O'Bryan MK; Lopes AM; Conrad DF; ; Punab M; Laan M
Hum Reprod; 2022 Jun; 37(7):1652-1663. PubMed ID: 35535697
[TBL] [Abstract][Full Text] [Related]
5. Secondary findings from clinical genomic sequencing: prevalence, patient perspectives, family history assessment, and health-care costs from a multisite study.
Hart MR; Biesecker BB; Blout CL; Christensen KD; Amendola LM; Bergstrom KL; Biswas S; Bowling KM; Brothers KB; Conlin LK; Cooper GM; Dulik MC; East KM; Everett JN; Finnila CR; Ghazani AA; Gilmore MJ; Goddard KAB; Jarvik GP; Johnston JJ; Kauffman TL; Kelley WV; Krier JB; Lewis KL; McGuire AL; McMullen C; Ou J; Plon SE; Rehm HL; Richards CS; Romasko EJ; Miren Sagardia A; Spinner NB; Thompson ML; Turbitt E; Vassy JL; Wilfond BS; Veenstra DL; Berg JS; Green RC; Biesecker LG; Hindorff LA
Genet Med; 2019 May; 21(5):1100-1110. PubMed ID: 30287922
[TBL] [Abstract][Full Text] [Related]
6. The rate of secondary genomic findings in the Saudi population.
Aloraini T; Alsubaie L; Alasker S; Al Muitiri A; Alswaid A; Eyiad W; Al Mutairi F; Ababneh F; Alfadhel M; Alfares A
Am J Med Genet A; 2022 Jan; 188(1):83-88. PubMed ID: 34515413
[TBL] [Abstract][Full Text] [Related]
7. The ACMG SF v3.0 gene list increases returnable variant detection by 22% when compared with v2.0 in the ClinSeq cohort.
Johnston JJ; Brennan ML; Radenbaugh B; Yoo SJ; Hernandez SM; ; Lewis KL; Katz AE; Manolio TA; Biesecker LG
Genet Med; 2022 Mar; 24(3):736-743. PubMed ID: 34906458
[TBL] [Abstract][Full Text] [Related]
8. Frequency of actionable secondary findings in 7472 Korean genomes derived from the National Project of Bio Big Data pilot study.
Kim Y; Kim JM; Cho HW; Park HY; Park MH
Hum Genet; 2023 Nov; 142(11):1561-1569. PubMed ID: 37728764
[TBL] [Abstract][Full Text] [Related]
9. Noncancer-related Secondary Findings in a Cohort of 231 Children With Cancer and Their Parents.
Wagener R; Walter C; Surowy HM; Brandes D; Soura S; Alzoubi D; Yasin L; Fischer U; Dugas M; Borkhardt A; Brozou T
J Pediatr Hematol Oncol; 2023 Mar; 45(2):e244-e248. PubMed ID: 35537032
[TBL] [Abstract][Full Text] [Related]
10. Frequency of genomic secondary findings among 21,915 eMERGE network participants.
eMERGE Clinical Annotation Working Group
Genet Med; 2020 Sep; 22(9):1470-1477. PubMed ID: 32546831
[TBL] [Abstract][Full Text] [Related]
11. Clinically actionable secondary findings in 130 triads from sub-Saharan African families with non-syndromic orofacial clefts.
Oladayo A; Gowans LJJ; Awotoye W; Alade A; Busch T; Naicker T; Eshete MA; Adeyemo WL; Hetmanski JB; Zeng E; Adamson O; Adeleke C; Li M; Sule V; Kayali S; Olotu J; Mossey PA; Obiri-Yeboah S; Buxo CJ; Beaty T; Taub M; Donkor P; Marazita ML; Odukoya O; Adeyemo AA; Murray JC; Prince A; Butali A
Mol Genet Genomic Med; 2023 Oct; 11(10):e2237. PubMed ID: 37496383
[TBL] [Abstract][Full Text] [Related]
12. Actionable secondary findings in the 73 ACMG-recommended genes in 1559 Thai exomes.
Chetruengchai W; Shotelersuk V
J Hum Genet; 2022 Mar; 67(3):137-142. PubMed ID: 34621001
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of pathogenic/likely pathogenic variants in the 24 cancer genes of the ACMG Secondary Findings v2.0 list in a large cancer cohort and ethnicity-matched controls.
Kim J; Luo W; Wang M; Wegman-Ostrosky T; Frone MN; Johnston JJ; Nickerson ML; Rotunno M; Li SA; Achatz MI; Brodie SA; Dean M; de Andrade KC; Fortes FP; Gianferante M; Khincha P; McMaster ML; McReynolds LJ; Pemov A; Pinheiro M; Santiago KM; Alter BP; Caporaso NE; Gadalla SM; Goldin LR; Greene MH; Loud J; Yang XR; Freedman ND; Gapstur SM; Gaudet MM; Calista D; Ghiorzo P; Fargnoli MC; Nagore E; Peris K; Puig S; Landi MT; Hicks B; Zhu B; Liu J; Sampson JN; Chanock SJ; Mirabello LJ; Morton LM; Biesecker LG; Tucker MA; Savage SA; Goldstein AM; Stewart DR
Genome Med; 2018 Dec; 10(1):99. PubMed ID: 30583724
[TBL] [Abstract][Full Text] [Related]
14. Disclosure of secondary findings in exome sequencing of 2480 Japanese cancer patients.
Horiuchi Y; Matsubayashi H; Kiyozumi Y; Nishimura S; Higashigawa S; Kado N; Nagashima T; Mizuguchi M; Ohnami S; Arai M; Urakami K; Kusuhara M; Yamaguchi K
Hum Genet; 2021 Feb; 140(2):321-331. PubMed ID: 32710294
[TBL] [Abstract][Full Text] [Related]
15. The use of ACMG secondary findings recommendations for general population screening: a policy statement of the American College of Medical Genetics and Genomics (ACMG).
ACMG Board of Directors
Genet Med; 2019 Jul; 21(7):1467-1468. PubMed ID: 31019278
[No Abstract] [Full Text] [Related]
16. ACMG SF v3.1 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG).
Miller DT; Lee K; Abul-Husn NS; Amendola LM; Brothers K; Chung WK; Gollob MH; Gordon AS; Harrison SM; Hershberger RE; Klein TE; Richards CS; Stewart DR; Martin CL;
Genet Med; 2022 Jul; 24(7):1407-1414. PubMed ID: 35802134
[No Abstract] [Full Text] [Related]
17. A semiquantitative metric for evaluating clinical actionability of incidental or secondary findings from genome-scale sequencing.
Berg JS; Foreman AK; O'Daniel JM; Booker JK; Boshe L; Carey T; Crooks KR; Jensen BC; Juengst ET; Lee K; Nelson DK; Powell BC; Powell CM; Roche MI; Skrzynia C; Strande NT; Weck KE; Wilhelmsen KC; Evans JP
Genet Med; 2016 May; 18(5):467-75. PubMed ID: 26270767
[TBL] [Abstract][Full Text] [Related]
18. Physician-directed genetic screening to evaluate personal risk for medically actionable disorders: a large multi-center cohort study.
Haverfield EV; Esplin ED; Aguilar SJ; Hatchell KE; Ormond KE; Hanson-Kahn A; Atwal PS; Macklin-Mantia S; Hines S; Sak CW; Tucker S; Bleyl SB; Hulick PJ; Gordon OK; Velsher L; Gu JYJ; Weissman SM; Kruisselbrink T; Abel C; Kettles M; Slavotinek A; Mendelsohn BA; Green RC; Aradhya S; Nussbaum RL
BMC Med; 2021 Aug; 19(1):199. PubMed ID: 34404389
[TBL] [Abstract][Full Text] [Related]
19. ACMG SF v3.2 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG).
Miller DT; Lee K; Abul-Husn NS; Amendola LM; Brothers K; Chung WK; Gollob MH; Gordon AS; Harrison SM; Hershberger RE; Klein TE; Richards CS; Stewart DR; Martin CL;
Genet Med; 2023 Aug; 25(8):100866. PubMed ID: 37347242
[TBL] [Abstract][Full Text] [Related]
20. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics.
Kalia SS; Adelman K; Bale SJ; Chung WK; Eng C; Evans JP; Herman GE; Hufnagel SB; Klein TE; Korf BR; McKelvey KD; Ormond KE; Richards CS; Vlangos CN; Watson M; Martin CL; Miller DT
Genet Med; 2017 Feb; 19(2):249-255. PubMed ID: 27854360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
